136 related articles for article (PubMed ID: 1347667)
1. Kinetics of HIV-1 interactions with sCD4 and CD4+ cells: implications for inhibition of virus infection and initial steps of virus entry into cells.
Dimitrov DS; Willey RL; Martin MA; Blumenthal R
Virology; 1992 Apr; 187(2):398-406. PubMed ID: 1347667
[TBL] [Abstract][Full Text] [Related]
2. Correlation between kinetics of soluble CD4 interactions with HIV-1-Env-expressing cells and inhibition of syncytia formation: implications for mechanisms of cell fusion and therapy for AIDS.
Dimitrov DS; Hillman K; Manischewitz J; Blumenthal R; Golding H
AIDS; 1992 Mar; 6(3):249-56. PubMed ID: 1348943
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein.
Dimitrov DS; Hillman K; Manischewitz J; Blumenthal R; Golding H
J Virol; 1992 Jan; 66(1):132-8. PubMed ID: 1727475
[TBL] [Abstract][Full Text] [Related]
4. Relative inefficiency of soluble recombinant CD4 for inhibition of infection by monocyte-tropic HIV in monocytes and T cells.
Gomatos PJ; Stamatos NM; Gendelman HE; Fowler A; Hoover DL; Kalter DC; Burke DS; Tramont EC; Meltzer MS
J Immunol; 1990 Jun; 144(11):4183-8. PubMed ID: 2341717
[TBL] [Abstract][Full Text] [Related]
5. Two mechanisms of soluble CD4 (sCD4)-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) infectivity and their relation to primary HIV-1 isolates with reduced sensitivity to sCD4.
Orloff SL; Kennedy MS; Belperron AA; Maddon PJ; McDougal JS
J Virol; 1993 Mar; 67(3):1461-71. PubMed ID: 8437224
[TBL] [Abstract][Full Text] [Related]
6. The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entry. Interaction between SPMG and HIV-1 rgp120 and CD4 molecule.
Meiyu G; Fuchuan L; Xianliang X; Jing L; Zuowei Y; Huashi G
Antiviral Res; 2003 Jul; 59(2):127-35. PubMed ID: 12895696
[TBL] [Abstract][Full Text] [Related]
7. Functional Mimetics of the HIV-1 CCR5 Co-Receptor Displayed on the Surface of Magnetic Liposomes.
Kuzmina A; Vaknin K; Gdalevsky G; Vyazmensky M; Marks RS; Taube R; Engel S
PLoS One; 2015; 10(12):e0144043. PubMed ID: 26629902
[TBL] [Abstract][Full Text] [Related]
8. Naturally occurring soluble CD4 in patients with human immunodeficiency virus infection.
Peakman M; Senaldi G; Foote N; McManus TJ; Vergani D
J Infect Dis; 1992 May; 165(5):799-804. PubMed ID: 1349032
[TBL] [Abstract][Full Text] [Related]
9. Blocking of human immunodeficiency virus infection depends on cell density and viral stock age.
Layne SP; Merges MJ; Spouge JL; Dembo M; Nara PL
J Virol; 1991 Jun; 65(6):3293-300. PubMed ID: 1674549
[TBL] [Abstract][Full Text] [Related]
10. Dissociation of gp120 from HIV-1 virions induced by soluble CD4.
Moore JP; McKeating JA; Weiss RA; Sattentau QJ
Science; 1990 Nov; 250(4984):1139-42. PubMed ID: 2251501
[TBL] [Abstract][Full Text] [Related]
11. Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events.
Ho HT; Fan L; Nowicka-Sans B; McAuliffe B; Li CB; Yamanaka G; Zhou N; Fang H; Dicker I; Dalterio R; Gong YF; Wang T; Yin Z; Ueda Y; Matiskella J; Kadow J; Clapham P; Robinson J; Colonno R; Lin PF
J Virol; 2006 Apr; 80(8):4017-25. PubMed ID: 16571818
[TBL] [Abstract][Full Text] [Related]
12. Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with CD4.
Zhang W; Godillot AP; Wyatt R; Sodroski J; Chaiken I
Biochemistry; 2001 Feb; 40(6):1662-70. PubMed ID: 11327825
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic Correlates of HIV-1 Macrophage Tropism.
Arrildt KT; LaBranche CC; Joseph SB; Dukhovlinova EN; Graham WD; Ping LH; Schnell G; Sturdevant CB; Kincer LP; Mallewa M; Heyderman RS; Rie AV; Cohen MS; Spudich S; Price RW; Montefiori DC; Swanstrom R
J Virol; 2015 Nov; 89(22):11294-311. PubMed ID: 26339058
[TBL] [Abstract][Full Text] [Related]
14. Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor.
Dey B; Del Castillo CS; Berger EA
J Virol; 2003 Mar; 77(5):2859-65. PubMed ID: 12584309
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamic and kinetic analysis of sCD4 binding to HIV-1 virions and of gp120 dissociation.
Moore JP; Klasse PJ
AIDS Res Hum Retroviruses; 1992 Apr; 8(4):443-50. PubMed ID: 1599754
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD4 enhances simian immunodeficiency virus SIVagm infection.
Werner A; Winskowsky G; Kurth R
J Virol; 1990 Dec; 64(12):6252-6. PubMed ID: 1700834
[TBL] [Abstract][Full Text] [Related]
17. Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses.
Dey B; Lerner DL; Lusso P; Boyd MR; Elder JH; Berger EA
J Virol; 2000 May; 74(10):4562-9. PubMed ID: 10775592
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the noncovalent complex of human immunodeficiency virus glycoprotein 120 with its cellular receptor CD4 by matrix-assisted laser desorption/ionization mass spectrometry.
Borchers C; Tomer KB
Biochemistry; 1999 Sep; 38(36):11734-40. PubMed ID: 10512629
[TBL] [Abstract][Full Text] [Related]
19. High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.
Daar ES; Li XL; Moudgil T; Ho DD
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6574-8. PubMed ID: 2395859
[TBL] [Abstract][Full Text] [Related]
20. Analysis of synergism/antagonism between HIV-1 antibody-positive human sera and soluble CD4 in blocking HIV-1 binding and infectivity.
Kennedy MS; Orloff S; Ibegbu CC; Odell CD; Maddon PJ; McDougal JS
AIDS Res Hum Retroviruses; 1991 Dec; 7(12):975-81. PubMed ID: 1687500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
